Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)

The summary for the Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement (FOA) is to provide continued support for the National Swine Resource and Research Center (NSRRC). The NSRRC serves as a central resource for the creation of genetically modified swine in response to the needs of the community and the cryopreservation of genetic stocks, procurement, and distribution of those swine, reagents, and their biological materials; and as a source of information and training related to the use of these animals in biomedical research as models of human health and disease.

Federal Grant Title:	Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-21-356
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.233, 93.351, 93.837, 93.838, 93.839, 93.840, 93.855
CFDA Descriptions:	Information not provided
Current Application Deadline:	September 25th, 2022
Original Application Deadline:	September 25th, 2022
Posted Date:	December 3rd, 2021
Creation Date:	December 3rd, 2021
Archive Date:	October 25th, 2022
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 24th, 2022

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Announcement for additional eligibility details.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-21-356.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARR...; • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...; • Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabet...; • Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U0...; • NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Pare...; • Ancillary Studies in Clinical Trials (R01); • Opportunity PA-08-021; • Research Demonstration and Dissemination Grants (R18)
More Grants from the National Institutes of Health: • Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (R...; • Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional); • NIH Research Program Projects (Parent P01 Clinical Trial Optional); • Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R...; • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028...